4.6 Article

In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Proton Pump Inhibitors Reduce the Risk of Neoplastic Progression in Patients With Barrett's Esophagus

Florine Kastelein et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)

Article Gastroenterology & Hepatology

Impact of Endoscopic Surveillance on Mortality From Barrett's Esophagus-Associated Esophageal Adenocarcinomas

Douglas A. Corley et al.

GASTROENTEROLOGY (2013)

Review Medicine, General & Internal

Barrett Esophagus and Risk of Esophageal Cancer A Clinical Review

Stuart Jon Spechler

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Article Cell Biology

Development and characterization of an organotypic model of Barrett's esophagus

Rachelle E. Kosoff et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2012)

Article Gastroenterology & Hepatology

Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis

M. Frazzoni et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)

Review Gastroenterology & Hepatology

Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia

K. R. McQuaid et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)

Article Gastroenterology & Hepatology

Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells

Xiaofang Huo et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)

Article Nutrition & Dietetics

Apple juice intervention modulates expression of ARE-dependent genes in rat colon and liver

Buelent Soyalan et al.

EUROPEAN JOURNAL OF NUTRITION (2011)

Article Gastroenterology & Hepatology

American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus

Stuart J. Spechler et al.

GASTROENTEROLOGY (2011)

Review Biochemistry & Molecular Biology

Regulation of NF-E2-Related Factor 2 Signaling for Cancer Chemoprevention: Antioxidant Coupled with Antiinflammatory

Rong Hu et al.

ANTIOXIDANTS & REDOX SIGNALING (2010)

Article Oncology

Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak?

Heiko Pohl et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)

Article Gastroenterology & Hepatology

Protective effects of glycoursodeoxycholic acid in Barrett's esophagus cells

A. Goldman et al.

DISEASES OF THE ESOPHAGUS (2010)

Review Oncology

OPINION γH2AX and cancer

William M. Bonner et al.

NATURE REVIEWS CANCER (2008)

Article Gastroenterology & Hepatology

Characterization of telomerase-immortalized, non-neoplastic, human Barrett's cell line (BAR-T)

K. R. Jaiswal et al.

DISEASES OF THE ESOPHAGUS (2007)

Article Gastroenterology & Hepatology

Ursodeoxycholic acid and superoxide anion

Predrag Ljubuncic et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2005)

Review Biochemistry & Molecular Biology

Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation

M Kobayashi et al.

ANTIOXIDANTS & REDOX SIGNALING (2005)

Review Immunology

The role of DNA breaks in genomic instability and tumorigenesis

KD Mills et al.

IMMUNOLOGICAL REVIEWS (2003)

Article Pharmacology & Pharmacy

Antioxidant properties of ursodeoxycholic acid

D Lapenna et al.

BIOCHEMICAL PHARMACOLOGY (2002)

Review Medicine, General & Internal

Ursodeoxycholic acid therapy in hepatobiliary disease

KV Kowdley

AMERICAN JOURNAL OF MEDICINE (2000)